Panobinostat in combination with bortezomib in patients with relapsed or refractory peripheral T-cell lymphoma: an open-label, multicentre phase 2 trial.
about
T-cell lymphomas, a challenging disease: types, treatments, and future.Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma.Innovation in non-Hodgkin lymphoma drug discovery: what needs to be done?Reply to the letter to the editor 'Epstein-Barr virus reactivation in extranodal natural killer/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsin, histone deacetylase (HDAC) inhibitors when coEpigenetic targeting of Notch1-driven transcription using the HDACi panobinostat is a potential therapy against T-cell acute lymphoblastic leukemia.Histone deacetylase (HDAC) inhibitors when combined with a proteasome inhibitor are safe and effective in patients with extranodal natural killer/T-cell lymphoma (ENKTL).
P2860
Panobinostat in combination with bortezomib in patients with relapsed or refractory peripheral T-cell lymphoma: an open-label, multicentre phase 2 trial.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Panobinostat in combination wi ...... el, multicentre phase 2 trial.
@ast
Panobinostat in combination wi ...... el, multicentre phase 2 trial.
@en
type
label
Panobinostat in combination wi ...... el, multicentre phase 2 trial.
@ast
Panobinostat in combination wi ...... el, multicentre phase 2 trial.
@en
prefLabel
Panobinostat in combination wi ...... el, multicentre phase 2 trial.
@ast
Panobinostat in combination wi ...... el, multicentre phase 2 trial.
@en
P2093
P1476
Panobinostat in combination wi ...... el, multicentre phase 2 trial.
@en
P2093
Chun Hsien Yeap
Colin Phipps
SGH651 Investigators
Sathish Gopalakrishnan Kumar
Soo Chin Ng
Soo Yong Tan
Soon Thye Lim
P304
P356
10.1016/S2352-3026(15)00097-6
P577
2015-07-07T00:00:00Z